Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis

Vancomycin has been shown to affect tumor necrosis factor-alpha (TNF-α) pathways as an immunomodulator; this is thought to be separate from its function as an antibiotic [1]. Previous studies have shown that oral vancomycin (OV) is an effective treatment for concomitant primary sclerosing cholangiti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abarbanel, David N., Seki, Scott M., Davies, Yinka, Marlen, Natalie, Benavides, Joseph A., Cox, Kathleen, Nadeau, Kari C., Cox, Kenneth L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3565076/
https://ncbi.nlm.nih.gov/pubmed/23054338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-012-9801-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller